VANCOUVER, BC--(Marketwired - September 26, 2016) -
THC BioMed Intl Ltd. ("THC" or the "Company")(CSE: THC)(OTC PINK: THCBF)(FRANKFURT: TFHC) is
pleased to announce that it has signed an LOI to purchase 100% of Clone Shipper, a US based company, specializing in packaging
products used to transport live plants, for 1 Million USD.
"I am pleased to have the opportunity to make this strategic purchase. Purchasing Clone Shipper allows THC to
penetrate the US and the International Cannabis market, while remaining in line with the US and International laws, by not
dealing directly with cannabis in countries where cannabis remains Federally illegal."
"The Global demand for Securely shipping Live plants is increasing with the legalization of Medical Cannabis.
This is the early formation of our Global footprint we intend to place in the International Cannabis Market Place." announced
John Miller, THC BioMed Intl CEO and President.
Clone shipper is currently the only device that meets Canadian and Federal International laws governing the
transportation of controlled live plants.
THC intends to strengthen the patents protecting this Device and will ensure that this invention is protected
under international laws.
Clone Shipper products are currently available for sale at gardening supply outlets throughout the USA. Clone
shipper is also available on popular sites like Amazon.com International online sales and more information on the company can be
found at www.cloneshipper.com
Management will continue to employ fiscal discipline as we asses and strategically move forward in building an
international vertically integrated Cannabis conglomerate. Management continues to work diligently to increase shareholder value
and meet the milestones it has set out to shareholders.
THC's vision is to be on the leading edge of scientific research, development of products and services related to
the medical cannabis industry while creating a standard of excellence. As the industry develops, it will become more important to
focus on scientific research and development of products and services related to medical cannabis. Management believes THC is
well-positioned to be in the forefront of this rapidly growing industry.
Please visit our website for a more detailed description of our business and services available. www.thcbiomed.com
Forward-Looking Information:
This press release may include forward-looking information within the meaning of Canadian securities legislation,
concerning the business of THC. Forward-looking information is based on certain key expectations and assumptions made by the
management of THC. Although THC believes that the expectations and assumptions on which such forward-looking information is based
are reasonable, undue reliance should not be placed on the forward-looking information because THC can give no assurance that
they will prove to be correct. Forward-looking statements contained in this press release are made as of the date of this press
release. THC disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new
information, future events or results or otherwise, other than as required by applicable securities laws.